PortfoliosLab logo

Can-Fite BioPharma Ltd. (CANF)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info


Trading Data

Previous Close$0.91
Year Range$0.83 - $2.34
EMA (50)$0.94
EMA (200)$1.28
Average Volume$117.80K
Market Capitalization$24.79M

CANFShare Price Chart

Chart placeholderClick Calculate to get results


The chart shows the growth of $10,000 invested in Can-Fite BioPharma Ltd. on Nov 12, 2012 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $111 for a total return of roughly -98.89%. All prices are adjusted for splits and dividends.

CANF (Can-Fite BioPharma Ltd.)
Benchmark (^GSPC)

CANFReturns in periods

Returns over 1 year are annualized


CANFMonthly Returns Heatmap

Chart placeholderClick Calculate to get results

CANFSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Can-Fite BioPharma Ltd. Sharpe ratio is -0.62. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

CANF (Can-Fite BioPharma Ltd.)
Benchmark (^GSPC)

CANFDividend History

Can-Fite BioPharma Ltd. granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to $0.00 per share.


Dividend yield


CANFDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

CANF (Can-Fite BioPharma Ltd.)
Benchmark (^GSPC)

CANFWorst Drawdowns

The table below shows the maximum drawdowns of the Can-Fite BioPharma Ltd.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Can-Fite BioPharma Ltd. is 99.36%, recorded on May 12, 2022. The portfolio has not recovered from it yet.



To Bottom


To Recover



-99.36%Dec 24, 20132110May 12, 2022
-40%Nov 12, 201248Sep 10, 201313Oct 1, 201361
-20.11%Oct 21, 20138Oct 30, 201313Nov 18, 201321
-19.97%Dec 2, 20131Dec 2, 201315Dec 23, 201316
-14.08%Oct 3, 20135Oct 9, 20136Oct 17, 201311

CANFVolatility Chart

Current Can-Fite BioPharma Ltd. volatility is 40.02%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

CANF (Can-Fite BioPharma Ltd.)
Benchmark (^GSPC)

Portfolios with Can-Fite BioPharma Ltd.

Loading data...